SCHEMBL8290402

SCHEMBL8290402

COCCCN1C(=O)/C(=C\C2=CCC(c3ccccc3N=O)O2)SC1=S

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.42
KMT2A Q03164 6/20 0.42
MAPT P10636 5/20 0.42
NPC1 O15118 2/20 0.42
RAB9A P51151 2/20 0.42
USP2 O75604 1/20 0.42
LMNA P02545 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
TSHR P16473 1/20 0.40
CYP2C19 P33261 1/20 0.40
HSD17B3 P37058 1/20 0.40
ALDH1A1 P00352 2/20 0.38
MAPK1 P28482 2/20 0.38
TDP1 Q9NUW8 1/20 0.38
MCHR1 Q99705 1/20 0.38
AKR1B1 P15121 1/20 0.38
MITF O75030 1/20 0.38
CTNNB1 P35222 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8288295 0.71 MEN1 (0.55) MEN1KMT2AMAPTUSP2LMNA
SCHEMBL3893517 0.69 MEN1 (0.69) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL3893522 0.69 MEN1 (0.69) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL8288292 0.68 CRHBP (0.55) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL13766517 0.67 MAPT (0.45) MEN1KMT2AMAPTUSP2ALDH1A1
SCHEMBL8289154 0.66 FFAR1 (0.56) MEN1KMT2AMAPTUSP2LMNA
SCHEMBL8289161 0.63 MEN1 (0.56) MEN1KMT2AMAPTRAB9AUSP2
SCHEMBL7704002 0.63 HSD17B3 (0.55) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL8537491 0.63 HSD17B3 (0.55) MEN1KMT2AMAPTNPC1RAB9A
SCHEMBL7704006 0.63 HSD17B3 (0.55) MEN1KMT2AMAPTNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005041951-A2 RHODANINE DERIVATIVES FOR USE AS ANTIVIRAL AGENTS RIGEL PHARMACEUTICALS, INC. (US) 2005-05-12 WO disclosed